| Followers | 91 |
| Posts | 9926 |
| Boards Moderated | 0 |
| Alias Born | 08/09/2006 |
Saturday, October 17, 2015 8:29:48 AM
I think where people get confused with this company is that this is a company going through a restructuring. If you need to be restructured that means you are in a bad financial position. If you have good IP it can be done.
Bears are looking at this like its a normal operating company. We know all the flaws, that is typical for a company being restructured. The value gets unlocked when that is completed and they come out clean on the other side.
The balance sheet is all but cleaned up now and that is typically the biggest obstacle in a restructuring. Over 90% of the debt is now gone. We have an amazing asset in Radiogel. At the same time the company has been cleaning up the financial mess for the last 9 months, they've also been able to move RadioGel forward with the Isotherapeutics deal and their conversations with the FDA. Next will be to get some cash on the balance sheet. Again, ALL biotech/med device companies need to raise cash, so this isn't a negative. When cash finally does get raised its actually a catalyst bc the financial overhang has been removed and BK concerns are gone.
So when people come on here on a daily basis saying the same obvious things over and over it starts to get comical......they clearly don't understand the process
Bears are looking at this like its a normal operating company. We know all the flaws, that is typical for a company being restructured. The value gets unlocked when that is completed and they come out clean on the other side.
The balance sheet is all but cleaned up now and that is typically the biggest obstacle in a restructuring. Over 90% of the debt is now gone. We have an amazing asset in Radiogel. At the same time the company has been cleaning up the financial mess for the last 9 months, they've also been able to move RadioGel forward with the Isotherapeutics deal and their conversations with the FDA. Next will be to get some cash on the balance sheet. Again, ALL biotech/med device companies need to raise cash, so this isn't a negative. When cash finally does get raised its actually a catalyst bc the financial overhang has been removed and BK concerns are gone.
So when people come on here on a daily basis saying the same obvious things over and over it starts to get comical......they clearly don't understand the process
Recent RDGL News
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 09:14:29 PM
